August 28, 2014 8:32 PM ET

Health Care Technology

Company Overview of PEPID, LLC

Executive Profile

Mark Rosenbloom MBA, M.D., FACEP

Founder and Chief Executive Officer, PEPID, LLC
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background

Dr. Mark Rosenbloom, MBA, MD, FACEP founded The Unicorn Children's Foundation and serves as its Chairman. Dr. Rosenbloom also founded PEPID, LLC in 1994 and serves as its Chief Executive Officer. He started his ascent in the corporate world, served as Executive Vice President and Director of Information Technology of America's 3rd largest news stand publishing company. Dr. Rosenbloom is a Board-certified emergency physician and an Adjunct Associate Professor of Clinical ...

Corporate Headquarters

1840 Oak Avenue
Evanston, Illinois 60201

United States

Phone: 847-491-9100
Fax: 866-681-8207

Board Members Memberships

There is no Board Members Memberships data available.

Education

MBA 1978
The Leland Stanford Junior University
MD
Northwestern University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PEPID, LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.